![Drew Moghanaki: Why it’s crucial to engage patients when developing informational statements](https://oncodaily.com/pub/uploads/2024/08/ZLzptl93_400x400-e1724077093710.jpg)
Photo from Drew Moghanaki/X
Aug 24, 2024, 13:55
Drew Moghanaki: Why it’s crucial to engage patients when developing informational statements
Drew Moghanaki shared on X:
“Patient communication is more effective when using “testimonials” versus “informational statements”. Hence, why it’s crucial to engage patients when developing informational statements.”
Dr. Drew Moghanaki, a Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology, UCLA. He holds the Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at the same university.
He specializes in treating lung cancer and other thoracic malignancies, focusing on advanced radiation therapy techniques like stereotactic body radiation therapy (SBRT), magnetic resonance-guided radiation therapy (MRgRT), and intensity-modulated radiation therapy (IMRT).